Drug ID: | NPD4374 |
Drug Name: | |
Molecular Formula: | C21H20N4 |
Canonical SMILES: | [nH]1ccc(=Nc2ccc(cc2)NCCc2c[nH]c3c2cccc3)cc1 |
Standard InCHI: | InChI=1S/C21H20N4/c1-2-4-21-20(3-1)16(15-24-21)9-14-23-17-5-7-18(8-6-17)25-19-10-12-22-13-11-19/h1-8,10-13,15,23-24H,9,14H2,(H,22,25) |
Standard InCHIKey: | CEGSUKYESLWKJP-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002133 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 11609586 |
ChEBI | |
CAS Number |
Molecular Weight | 328.17 |
ALogP | -1.4194 |
MLogP | 3.33 |
XLogP | 4.789 |
HDA | 4 |
HBD | 3 |
Rotatable Bonds | 5 |
TPSA | 52.21 |
RO5 Violation | 0 |